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Abstract
Sparse fur with abnormal skin and hair (spf-ash) mice are deficient in ornithine carbamoyltransferase (OCT) activity, but
their OCT protein is kinetically normal. We administered ammonium chloride to spf-ash mice, in order to analyze ammonia
metabolism and to find a rationale for the therapy of OCT deficiency. Ammonia concentration in the liver of spf-ash mice
increased to a level much higher than in the control. Ammonium chloride injection caused an increase in ornithine (Orn)
5 min after injection and an increase in the sum of Orn, citrulline (Cit) and arginine (Arg) for at least 15 min in the liver of
control mice, but no increase in Orn, Cit and Arg in the liver of spf-ash mice. Treatment of spf-ash mice with Arg 5^20 min
prior to the injection of ammonium chloride kept the hepatic ammonia concentration at a level comparable to that without
the load. A significant reciprocal relationship between ammonia and Orn concentrations in the liver of spf-ash mice 5 min
after an ammonium chloride load with or without Arg strongly suggests that ammonia disposal is dependent on the supply of
Orn. In spf-ash mice loaded with tryptone as a nitrogen source, Arg supplementation showed a dramatic decrease in urinary
orotic acid excretion in a dose-dependent manner. Similar effects were observed with Cit and Orn at the same dose, and a
long-lasting effect with an ornithine aminotransferase inactivator, 5-(fluoromethyl)ornithine, at a much lower dose. The rate
of urea formation in liver perfused with ammonium chloride was lower in spf-ash mice than in controls, but with the addition
of Orn to the medium it increased to a similar level in control and spf-ash mice. These results indicate that OCT is not
saturated with Orn in vivo under physiological conditions and that the administration or enrichment of the urea cycle
intermediate amino acids enhances the OCT reaction so that the ammonia metabolism of OCT-deficient spf-ash mice is at
least partially normalized. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Ornithine carbamoyltransferase (OCT) de¢ciency
is the most frequent enzyme de¢ciency in the urea
cycle [1]. The genetic defects and the enzyme abnor-
malities have been extensively studied [2,3]. Two
kinds of OCT-de¢cient animal models, sparse fur
(spf) and sparse fur with abnormal skin and hair
(spf-ash) mice, have been analyzed [4^6] and used
as model systems for gene therapy [6^9]. A mutation
causing an amino acid substitution and kinetic ab-
normalities, such as a higher Km value for ornithine
(Orn) and a higher pH optimum, was found in spf
mice [4,5]. The mutation in spf-ash mice causes splic-
ing abnormalities and an amino acid substitution
resulting in the decrease in enzyme protein (about
5% of control), which, however, has a normal Km
value for Orn [4,6]. Transgenic spf-ash mice carrying
recombinant DNA composed of 1.3 kb of the pro-
moter region of the rat OCT gene fused onto rat
OCT cDNA [10] showed an OCT activity of about
10% and 30% of the control levels in the liver and
small intestine, respectively. These mice appeared
normal without having sparse fur [11]. They are,
however, not completely normal, because they ex-
crete a larger amount of orotic acid in the urine after
nitrogen load and become labile after tick infection
[12].
It is supposed that Orn is one of the most impor-
tant regulatory factors for the operation of the urea
cycle. Orn concentration in the liver changes in re-
sponse to changes in urea synthesis [13^15]. Intra-
peritoneal injection of ammonium chloride to rats
causes a transient increase in Orn concentration in
the liver [14]. It is, however, not clear whether these
changes in Orn concentration play a role in urea
synthesis under physiological and pathological con-
ditions. A number of papers have described that ar-
ginine (Arg) or Orn administration lowers blood am-
monia and the mortality rate of animals intoxicated
with ammonium salts or with liver damage [16^19].
Objections to these experiments are that the OCT
step is not rate-limiting, because OCT activity is
much higher than carbamoylphosphate synthetase I
or argininosuccinate synthetase (ASS) activities.
An ornithine aminotransferase (OAT) inhibitor,
5-(£uoromethyl)ornithine (5-FMOrn), which causes
the elevation of Orn concentration in the liver, plas-
ma and brain [20] was reported to have a protective
e¡ect in animal models with hyperammonemia, but
less in rats with portocaval shunts [21^23]. 5-FMOrn
administered to OCT-de¢cient spf mice showed
marked e¡ects on hyperammonemia, orotic aciduria
and abnormal behavior [24]. This is considered to be
due to the supply of endogenous Orn to the abnor-
mal OCT in spf mice which have a higher Km value
for Orn. In our experiments, we used spf-ash mice
which have OCT with normal kinetic properties, and
showed that even in the liver of spf-ash mice with
only 5% of control OCT activity, supplementation of
Orn has a marked therapeutic e¡ect, indicating that
OCT is not saturated in vivo with Orn.
A part of this study was presented at a meeting on
nutritional and acid-base aspects of amino acid me-
tabolism and published [25].
2. Materials and methods
2.1. Animals
Control male mice, OCT-de¢cient spf-ash hemizy-
gous mice (XP/Y) and spf-ash mice with OCT trans-
gene (transgenic spf-ash mice; XP/Y, +/3) from the
C57BL strain [10,11] were used in the present study.
In some experiments, we also used spf mice from
the BALB/C strain. The mating programs were de-
scribed by Shimada et al. [11]. Heterozygous female
mice (XP/X) were mated with transgenic male mice
(+/3), descendants of No. 94, described by Muraka-
mi et al. [10]. DNA diagnosis of spf-ash gene and
OCT transgene was performed as described by
Kobayashi et al. [26] using genomic DNA isolated
by the method of Qi et al. [27].
2.2. Animal treatment
Mice were maintained on laboratory chow (24%
protein) from Clea Japan and used for experiments
at 60^70 days of age. After overnight starvation, they
were subjected to intraperitoneal injections of 0.2 M
ammonium chloride (2 mmol/kg body weight) be-
tween 10.00 and 11.00 in the experiments shown in
Figs. 1^3, and additionally to 0.2 M neutralized Arg
(4 mmol/kg) or 0.2 M sodium chloride (as control
experiments) 5 min^2 h prior to ammonium chloride
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injection in the experiments shown in Fig. 4. Five, 10
or 15 min after ammonium chloride injection, the
mice were killed by cervical dislocation. For amino
acid and ammonia analysis, the liver was taken out
and freeze-clamped as quickly as possible in a solid
CO2/acetone mixture. For the experiments shown in
Figs. 6 and 7, 1 g of tryptone (Difco Laboratories,
Detroit, MI, USA) was dissolved in 3 ml of water, or
0.05, 0.1, 0.2 or 0.4 M neutralized Arg, 0.2 M neu-
tralized Orn or 0.2 M citrulline (Cit). Amounts of
tryptone and amino acids supplemented were calcu-
lated from the volume change by the addition of
tryptone powder. The tryptone solution (20 ml/kg
body weight), 5.6 g/kg or 46 mmol equivalent of
amino acids/kg, was administered to spf-ash mice
through a gastric tube between 9.00 and 10.00.
Then, the mice were housed individually in metabolic
cages for 2 h, to collect urine. Blood was taken by
heart puncture under ethylether anesthesia at the
times indicated in the ¢gure. In the experiments
shown in Figs. 6 and 7, 5-FMOrn was administered
intraperitoneally at a dose of 20 mg/kg (0.1 mmol/kg)
twice at 9.00 and 18.00 1 day before the tryptone
load. This study was carried out according to the
Guide for Animal Experimentation, Faculty of Med-
icine, Kagoshima University.
2.3. Liver perfusion
Liver perfusion was performed essentially as de-
scribed by Nakajima et al. [28]. After anesthesia
with an intraperitoneal injection of sodium pentobar-
bital (0.05 mg/g), liver was perfused in situ with
Krebs-Henseleit bicarbonate bu¡er (pH 7.4, 36‡C,
saturated with 95% oxygen and 5% carbon dioxide)
in a noncirculating system [29]. A Clark-type oxygen
Fig. 1. Changes in ammonia concentration in the liver of con-
trol (a), spf-ash (F) and transgenic spf-ash (G) mice after am-
monium chloride injection. Mice (60^70 days old) were starved
overnight. Ammonium chloride solution (0.2 M; 2 mmol/kg
body weight) was intraperitoneally injected to control, spf-ash
and transgenic spf-ash mice at time 0. At the times indicated,
liver was taken out and freeze-clamped as quickly as possible.
Values are presented as means þ S.D. Numbers of animals are
17, 9, 12, and 7 for 0, 5, 10, and 15 min of control mice; 23, 7,
10, and 6 for spf-ash mice; 6, 11, 12, and 5 for transgenic spf-
ash mice. Statistically signi¢cant di¡erences from the 0 min val-
ue of each group are *P6 0.05 and **P6 0.01.
Fig. 2. Changes in Glu, Ala, Asp and GluNH2 concentrations
in the liver of control (a), spf-ash (F) and transgenic spf-ash
(G) mice after ammonium chloride injection. Experimental de-
tails are as described in the legend to Fig. 1.
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electrode (Instech, model 125/05) was used to meas-
ure oxygen concentration of the e¥uent perfusate.
Perfusate and substrate were pumped into the liver
through a cannula inserted in the portal vein, and the
e¥uent perfusate was collected via a cannula placed
in the inferior vena cava. The liver was perfused at a
constant £ow rate of 6^8 ml/min. Perfusion was con-
sidered successful if the liver did not swell or leak
perfusate, and if oxygen consumption was stable.
Ammonium chloride and L-ornithine-monohydro-
chloride (Orn) were dissolved in Krebs-Henseleit
bicarbonate bu¡er to a ¢nal concentration of 1 mM.
2.4. Assay methods
Freeze-clamped livers were pulverized in liquid ni-
trogen, and the resultant powder was homogenized
with 4 vols. of 3% sulfosalicylic acid. After neutral-
ization with 1 M sodium bicarbonate, ammonia con-
centration in the sulfosalicylic acid extract was as-
sayed by £ow injection analysis as described by
Svensson and Anfa«lt [30]. Ammonia was assayed
by £ow injection analysis with plasma separated
from heparinized blood. Amino acid concentrations
in the salicylic acid extract were determined with a
Hitachi 835 Amino Acid Analyzer (Hitachi, Japan).
Urinary orotic acid and creatinine were measured by
the methods of Kesner et al. [31] and Bonsnes and
Taussky [32], respectively. Urea was assayed with an
enzymatic method [33].
2.5. Materials
5-FMOrn was synthesized as described by Daune
et al. [20]. Other chemicals were of analytical grade
from Nacalai tesque (Kyoto).
2.6. Statistical methods
All data were analyzed using Student’s t-test for
unpaired samples. All values are expressed as
means þ S.D.
3. Results and discussion
3.1. Changes in ammonia and amino acid
concentrations in the liver of control, spf-ash and
transgenic spf-ash mice after intraperitoneal
injection of ammonium chloride
To test the ammonia metabolism of OCT-de¢cient
mice and the e¡ect of the OCT transgene, we injected
an ammonium chloride solution (2 mmol/kg body
weight) intraperitoneally to the overnight-fasted
mice, and measured the ammonia concentration in
the liver 5, 10 and 15 min after the injection. The
0 min ammonia level (without injection) of spf-ash
mice was signi¢cantly higher than the values of con-
trol and transgenic spf-ash mice (816 þ 268 vs.
638 þ 150 and 651 þ 103 nmol/g liver; P6 0.05). As
Fig. 3. Changes in concentrations of Orn, Cit and the sum of
Orn, Cit and Arg in the liver of control (a), spf-ash (F) and
transgenic spf-ash (G) mice after ammonium chloride injection.
Experimental details are as described in the legend to Fig. 1.
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shown in Fig. 1, ammonium chloride injection to
control mice caused a signi¢cant increase in liver
ammonia 5 min after injection, which then decreased
to a level lower than the 0 min value. In the case of
OCT-de¢cient spf-ash mice, the hepatic ammonia
level increased at 5 min to a level about 5 times
the 0 min value. Ammonia remained high until
10 min, then decreased to reach at 15 min a level
still 2 times higher than the 0 min value. In the
case of the transgenic spf-ash mice carrying rat
OCT transgene, the hepatic ammonia increased at
5 min to a level much higher than the control value,
but lower than the level of spf-ash mice. It decreased
to the 0 min level at 15 min. These results indicate
that the ammonia metabolism of OCT-de¢cient spf-
ash mice is defective and that the OCT transgene is
not su⁄cient to completely normalize the disturbed
ammonia metabolism of spf-ash mice.
Next we measured the amino acid concentrations
in the liver of the mice (Figs. 2 and 3). No signi¢cant
di¡erences in hepatic amino acid concentrations were
found between the groups at 0 min, except that the
glutamine (GluNH2) concentration was higher in spf-
ash mice than in control mice (3540 þ 692 vs.
3070 þ 586 nmol/g liver; P6 0.05). Orn and Cit con-
centrations were lower in spf-ash mice than in con-
trol mice at 0 min (Orn, 218 þ 49 vs. 249 þ 46 nmol/g,
P6 0.05; Cit, 36 þ 17 vs. 54 þ 23 nmol/g, P6 0.01).
After the ammonium chloride injection, no signi¢-
cant changes in glutamate (Glu) were observed in the
liver of control and transgenic spf-ash mice, while a
marked increase in Glu was found in spf-ash mice.
The levels were more than 2 times of the 0 min value
at 5 and 10 min, and slightly decreased at 15 min,
but were still much higher than at 0 min. The hepatic
alanine (Ala) and aspartate (Asp) levels changed sim-
ilarly after the ammonia administration; about
5-fold increases were seen in spf-ash and the trans-
genic spf-ash mice at 5 min, which decreased to the
0 min level of control and transgenic spf-ash mice at
10 min. The levels in spf-ash mice at 10 min were
signi¢cantly higher than the 0 min value. The Ala
level at 15 min of control mice was signi¢cantly low-
er than the 0 min value. It was unique that the
GluNH2 concentrations decreased after ammonium
chloride injection. The decreases were more marked
in control and transgenic spf-ash mice than in spf-
ash mice; the levels were signi¢cantly lower at 5 min
than the 0 min value and stayed low thereafter. In
the case of spf-ash mice, GluNH2 decreased gradu-
ally and was signi¢cantly lower at 10 and 15 min
than at 0 min. These results suggest that Ala and
Asp are transient ammonia acceptors under the con-
ditions of ammonium salt load, not only in OCT-
de¢cient mice, but also in control mice, while Glu
is a reservoir for an excess of ammonia in the
OCT-de¢cient mice. GluNH2 is known to be de-
graded in the periportal region of the hepatic lobulus
and synthesized in the pericentral region [34], and its
degradation is accelerated in the presence of ammo-
nia [35]. The degradation of GluNH2 may be active
both in control and spf-ash mice, although the simul-
taneous synthesis is probably more active in OCT-
de¢cient spf-ash mice because the sustained high con-
centration of ammonia in spf-ash mice accelerates
GluNH2 synthesis.
We measured the concentrations of the urea cycle
intermediate amino acids (Fig. 3). As stated above,
the Orn and Cit concentrations at 0 min were signi¢-
cantly lower in spf-ash mice than in controls. The
ammonium chloride injection to control mice caused
an increase in Orn at 5 min, which then decreased to
the 0 min level at 10 min. The Cit concentration
markedly increased after the Orn concentration had
decreased, and remained high until 15 min. The
Arg level was increased 2-fold from 28 þ 10 to
58 þ 21 nmol/g (P6 0.01) at 5 min, and then de-
creased to the basal level at 10 min (data not shown).
As a result, the sum of Orn+Cit+Arg concentrations
increased about 1.7-fold at 5 min and remained al-
most constant till 15 min. In the case of OCT-de¢-
cient spf-ash mice, none of the three urea cycle in-
termediate amino acids was increased. Not only spf-
ash mice, but also spf mice which are also OCT-de-
¢cient, having a kinetically mutant OCT, showed
similarly no increase in the urea cycle intermediate
amino acids after the intraperitoneal injection of
ammonium chloride (data not shown). In contrast,
the transgenic spf-ash mice showed no signi¢cant
transient increases in Orn and Arg but a gradual
increase in Cit. As a result, the sum of Orn+Cit+Arg
was increased to the level of the control mice at
15 min.
In 1978, Saheki et al. [14] described that the intra-
peritoneal injection of ammonium chloride in rats
caused a transient increase in hepatic Orn. Similar
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phenomena were observed in the control mice in the
present study. One di¡erence between rats and mice
was that the increase in Cit was prominent in mice,
but very weak in rats. It suggests that the ASS step is
more rate-limiting in mice than in rats. One of the
most important results shown in the present study is
that no increase in Orn or Orn+Cit+Arg was ob-
served in OCT-de¢cient mice including spf and spf-
ash. This suggests that OCT is involved in the in-
crease in the hepatic Orn after ammonium salt
load. One possibility is that the conversion of Orn
to Cit causes the increase in urea cycle intermediate
amino acids, because OAT is the major degradation
enzyme of the urea cycle intermediate amino acids,
and therefore, the conversion of Orn to Cit prevents
Orn from being degraded. However, this cannot be
the case, because after the ammonia salt load Orn
concentrations increased before the increase in Cit.
Another possibility is that an increase in Arg may be
the ¢rst event, although Arg is immediately con-
verted to Orn and therefore it is di⁄cult to observe
a signi¢cant increase in Arg. Arg is synthesized from
Cit, which is synthesized in the small intestine from
Glu via glutamic semialdehyde and Orn. OCT is also
involved in this pathway. The OCT activity in the
small intestine of spf-ash mice is 5% of the control,
while it is 30% in the small intestine of the transgenic
spf-ash mice. As Saheki et al. reported previously
[14], Orn is very low and not increased in the per-
fused liver, supplemented with ammonium salt, sug-
gesting that other organs may be involved in the
increase in the urea cycle intermediate amino acids
after ammonia salt load. This suggests the impor-
tance of OCT in the small intestine. The origin of
the increased hepatic Orn and the way to increase the
Orn concentration remain to be elucidated. Other
questions are whether the increase in the urea cycle
intermediate amino acids plays a role in the ammo-
nia metabolism in the liver, and if it does, whether
the supplementation of the urea cycle intermediate
amino acids helps to dispose of ammonia in the liver
of spf-ash mice. To test this, we supplied Arg intra-
peritoneally to spf-ash mice before the ammonium
chloride load.
Fig. 4. E¡ect of pretreatment with Arg on ammonia concentration in the liver of spf-ash mice injected with ammonium chloride
(AmCl). Spf-ash mice were treated with or without intraperitoneal injection of 0.2 M Arg (4 mmol/kg) or with 0.16 M sodium chlo-
ride (NaCl; 3.2 mmol/kg) 5 min^2 h prior to AmCl injection. Five minutes after AmCl injection, liver was taken out to measure am-
monia concentration. Values are presented as mean þ S.D. Numbers of animals (n) are shown in parentheses. Statistically signi¢cant
di¡erences between the groups are **P6 0.01.
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3.2. E¡ect of arginine supplementation prior to
ammonium chloride injection on ammonia
concentration in the liver
As shown in Fig. 4, pretreatment with Arg (4
mmol/kg body weight) 5^20 min prior to the ammo-
nium chloride injection prevented the increase in am-
monia in the liver of spf-ash mice at 5 min after
ammonium chloride load. The Arg e¡ect decreased
if the time elapsing between Arg administration and
ammonium chloride load increased, suggesting a rap-
id turnover of Arg and Orn. Under these conditions,
the Orn concentration in the liver decreased with
time. Fig. 5 represents relations between ammonia
and Orn concentrations in the liver of spf-ash mice
5 min after ammonium chloride load with and with-
out Arg pretreatment. When the former values were
plotted versus the reciprocals of the latter values, we
obtained a straight line, as shown in the insert of Fig.
5, indicating a signi¢cant linear relationship
(r2 = 0.68 and P6 0.05) between ammonia and the
reciprocal of ornithine levels. A signi¢cant ammo-
nia-decreasing e¡ect was observed with ornithine
concentrations at 400^600 nmol/g liver, which is
about the same level of control mice after ammo-
nium chloride load (Fig. 3). It is also noteworthy
that the Km value of OCT for ornithine is about
0.4 mM [4,36]. These results strongly suggest that
the ability to dispose of ammonia is dependent on
the supply of Orn, and that the increase in Orn after
the ammonium chloride challenge has a physiological
signi¢cance.
3.3. E¡ect of arginine, ornithine, citrulline and
5-(£uoromethyl)ornithine on orotic acid
excretion and plasma ammonia following oral
administration of tryptone to spf-ash mice
To further con¢rm the e¡ect of the urea cycle in-
termediate amino acids on the ammonia metabolism
of OCT-de¢cient spf-ash mice, we administered tryp-
tone (5.6 g/kg body weight) with or without Arg via
a gastric tube, and measured orotic acid excretion in
the urine collected for 2 h. The orotic acid excretion
in OCT-de¢cient mice was markedly decreased by
the introduction of OCT transgene [11,12,37,38], or
by viral vector-mediated gene therapy [7,9]. The or-
otic acid excretion decreased dose-dependently by the
Arg supplementation at doses between 0.8 and 6.4
mmol/kg body weight (data not shown). The Arg
at a dose of 0.8 mmol/kg caused a signi¢cant de-
crease in urinary orotic acid excretion (P6 0.01).
We achieved the lowest orotic acid excretion with
Arg at 6.4 mmol/kg. The lowest value was almost
similar to that of the transgenic spf-ash mice with
tryptone load without Arg, and was still higher
than control values [12]. Almost the same e¡ects
were obtained by the supplementation with the
same amount of Cit and Orn, as shown in Fig. 6.
We tested 5-FMOrn, a selective inactivator of
OAT introduced by Daune et al. [20], on orotic
acid excretion. 5-FMOrn at a dose of 20 mg/kg
(0.1 mmol/kg) was administered intraperitoneally
twice at 9.00 and 18.00 h 1 day before the tryptone
load. A dose of 5-FMOrn lower by a factor of 1/30
of the most e¡ective dose of Arg caused almost the
same e¡ect as Arg on orotic acid excretion. Its long-
Fig. 5. Relationship between ammonia and ornithine concentra-
tions in the liver of spf-ash mice 5 min after ammonium chlo-
ride load; e¡ect of pretreatment with arginine. Data on ammo-
nia and ornithine concentrations obtained in the experiments
shown in Fig. 4 were plotted in this ¢gure. The insert shows
the relation between ammonia concentration (nmol/g liver; Y)
and reciprocal number of ornithine concentration (g liver/nmol;
X). The regression equation was as follows: Y = 1320+444 000X.
The correlation coe⁄cient was r2 = 0.68 (P6 0.05). The curve in
the main ¢gure was drawn according to the equation.
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lasting e¡ect was remarkable. Because 5-FMOrn in-
activates OAT, it causes a dramatic increase in Orn
in the liver and other organs [20]. In the present
study, Orn, Cit and Arg concentrations in the liver
of spf-ash mice with 5-FMOrn treatment at 10.00 h
on the day of the experiments were 4000 þ 550,
149 þ 44 and 53 þ 15 nmol/g liver, respectively (with-
out ammonium chloride load, n = 5). Those in the
plasma without and with 5-FMOrn were 16 þ 4 and
835 þ 396 nmol/ml for Orn, 10 þ 3 and 29 þ 14 nmol/
ml for Cit, and 34 þ 7 and 46 þ 13 nmol/ml for Arg
(n = 5). It is also noteworthy that not only Orn, but
also Cit and Arg were elevated in the liver and plas-
ma due to 5-FMOrn, although the di¡erence was not
signi¢cant for plasma Arg. In the case of the trans-
genic spf-ash mice, administration of 5-FMOrn de-
creased the orotic acid excretion after tryptone load
from 2950 þ 1420 to 470 þ 150 nmol/mg creatinine,
which is within the normal range [12].
Next we measured plasma ammonia levels of spf-
ash mice following oral tryptone administration and
tested the e¡ect of 5-FMOrn. As shown in Fig. 7, the
plasma ammonia level was elevated following the
nitrogen load; the peak (781 þ 96 nmol/ml) was at
1 h after the administration, and the level was not
normalized at 2 h. When the mice were pretreated
with 5-FMOrn as described above, the plasma am-
monia (106 þ 22 nmol/ml) was not signi¢cantly di¡er-
ent from the value before the nitrogen load without
5-FMOrn (97 þ 69 nmol/ml). It was, however, still
higher than the value of control mice with the tryp-
tone load (55 þ 12 nmol/ml).
All these results suggest that the defective OCT
activity of spf-ash mice is not the only rate-limiting
parameter. The amount of Orn, or the urea cycle
intermediate amino acids, limits the ability of the
liver to detoxify ammonia. These considerations are
important for the treatment of OCT de¢ciency.
3.4. Urea synthesis from ammonium chloride as a
substrate in the perfused liver of control and
spf-ash mice
To further test the rate-limiting factors of urea
synthesis in the liver of OCT-de¢cient spf-ash mice,
we performed liver perfusion experiments and meas-
ured the rate of urea synthesis with ammonium
chloride as a substrate for the urea cycle in the ab-
Fig. 7. Plasma ammonia concentration of spf-ash mice intragas-
trically loaded with tryptone and e¡ect of 5-FMOrn) pretreat-
ment. Experimental procedures are described in Section 2.
Tryptone was administered at time 0. At the times indicated,
blood was taken by heart puncture under ethylether anesthesia.
Results of control mice receiving 0.2 M NaCl (4 mmol/kg) are
shown with an open circle, and spf-ash mice administered 0.16
M NaCl (1.6 mmol/kg) and 5-FMOrn (0.1 mmol/kg) with
closed and shaded squares, respectively. Values are presented as
means þ S.D. Numbers of animals are shown in parentheses.
Fig. 6. E¡ect of Arg, Cit and Orn supplementation and pre-
treatment with 5-FMOrn on urinary orotic acid excretion in
spf-ash mice following oral administration of tryptone. Tryp-
tone was dissolved in water (none), or in 0.2 M neutralized
Arg, Cit and Orn solution, and administered per os. Amount
of amino acid supplemented was 3.2 mmol/kg. 5-FMOrn was
injected intraperitoneally twice 1 day before the experimental
day, and tryptone solution in water was administered, as de-
scribed in Section 2. The mice were housed individually in a
metabolic cages for 2 h, to collect urine. Data were expressed
as Wmol orotic acid/mg creatinine (cr). Data on transgenic spf-
ash and control mice [12] are also presented.
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sence and presence of external Orn. The rate of urea
synthesis in perfused liver was determined by meas-
uring urea in the perfusate under £ow-through con-
ditions. As shown in Fig. 8A, addition of 1 mM
ammonium chloride following 10 min preperfusion
without external substrates caused an increase in
urea synthesis in the livers from control, spf-ash
and transgenic spf-ash mice. After the initial increase
in the rate of urea formation for about 4 min, it
further gradually increased with time in control
mice and, to a lesser degree, in transgenic spf-ash
mice, but it did not increase in the liver of spf-ash
mice. Ten min after addition of ammonium chloride
to the perfusion medium, there were signi¢cant dif-
ferences in the rate of urea synthesis between the
groups. The addition of 1 mM Orn increased the
rate of urea formation, which was not di¡erent be-
tween the groups (Fig. 8A). Withdrawal of Orn from
the perfusion medium caused again a signi¢cant dif-
ference in the rate between the groups. Withdrawal
of ammonium chloride caused ¢rst a rapid and then
a slow decrease in the rate in each group, and there
was no di¡erence in the rate between the groups.
When ammonium chloride and Orn were added to
the medium from the beginning, as shown in Fig. 8B,
a gradual increase in the rates of urea formation with
time was observed not only in control but also in spf-
ash mice, and no di¡erence in the rates between the
groups was found. The gradual increases in the rates
of urea formation may result from changes in N-ace-
tylglutamate or Orn which are well-known stimula-
tors of urea formation in perfused liver and in liver
slices [39^41]. Orn concentration in the perfused liver
in the presence of ammonium chloride was at a sim-
ilar level in control and spf-ash mice, at 42 þ 22 and
36 þ 11 nmol/g liver, respectively. A change in N-ace-
tylglutamate concentration is considered to be the
cause of the gradual increase in the rate of urea for-
mation in the experiments shown in Fig. 8B, because
1 mM Orn was added to the perfusion medium. Sa-
heki et al. [14] showed that the concentration of N-
acetylglutamate of perfused rat liver increased during
perfusion with ammonium chloride, although Orn
did not. In the experiments shown in Fig. 8A, the
rate of urea formation in spf-ash mice did not show a
gradual increase with time. It is because the defective
OCT step with low Orn would be rate-limiting even
though N-acetylglutamate concentration may have
increased. Only after the addition of Orn does any
step other than the OCT reaction become rate-limit-
ing.
The results show that addition of 1 mM Orn
caused no di¡erence in the rate of urea formation
between control and spf-ash mice. This indicates
that under the conditions of Orn supplementation,
the OCT step is not rate-limiting for urea formation,
even though spf-ash mice have only 5% of control
OCT activity. It should be noted that spf-ash mice
have a kinetically normal OCT, but no mutant OCT
with a higher Km value for Orn, as was found in spf
Fig. 8. Urea formation from ammonium chloride with or with-
out ornithine in the perfused liver of control (a), transgenic
spf-ash (G) and spf-ash (F) mice. The liver perfusion system
and the procedures are described in Section 2. The abscissa
shows the perfusion time. The ordinate shows the rate of urea
formation. 1 mM ammonium chloride (AmCl) and 1 mM orni-
thine were present in the medium during the period indicated.
Numbers of animals were 8, 4 and 7 for control, transgenic
spf-ash and spf-ash mice in A and 5 and 4 for control and spf-
ash mice in B, respectively. Statistically signi¢cant di¡erences
between the groups at the times indicated (20 and 40 min) are
*P6 0.05 and **P6 0.01.
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mice [4]. It has been reported that the hyperammo-
nemia and orotic aciduria of a patient with OCT
de¢ciency and kinetically abnormal OCT were ame-
liorated by a continuous supplement of arginine [42],
and that the hyperammonemia and orotic aciduria
of spf mice can be normalized by treatment with
5-FMOrn [24] which inactivates OAT and increases
Orn concentration beyond the high Km value of the
mutant OCT. The e¡ectiveness of 5-FMOrn on the
hyperammonemia of spf-ash mice implies that the
OCT reaction is not saturated with Orn in vivo,
and strongly suggests that the increase in Orn in
vivo following an ammonia load may play a physio-
logical role. Actually, the present study shows a sig-
ni¢cant reciprocal relationship between ammonia
and Orn concentrations under the conditions stated
in Fig. 5. From the results presented in this study, we
propose that supplying urea cycle intermediate ami-
no acids to patients with partial OCT de¢ciency is
clinically bene¢cial, and that OAT inhibitors such as
5-FMOrn may be even more e¡ective.
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